BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25633364)

  • 21. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
    Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
    Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between the dissected lymph node number and the prognosis in D(2) gastrectomy for gastric cancer].
    Liang H; Xue Q; Zhang RP; Hao XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):528-30. PubMed ID: 18000772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.
    Wu XJ; Miao RL; Li ZY; Bu ZD; Zhang LH; Wu AW; Zong XL; Li SX; Shan F; Ji X; Ren H; Ji JF
    Eur J Surg Oncol; 2015 Jul; 41(7):927-33. PubMed ID: 25913059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of metastatic lymph node ratio for gastric cancer patients with less than 15 lymph nodes dissection].
    Liu HG; Liang H; Deng JY; Wang L; Liang YX; Jiao XG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):151-4. PubMed ID: 23446476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques].
    Zhang CH; Wu AW; Li ZY; Zhang LH; Bu ZD; Wu XJ; Zong XL; Li SX; Shan F; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):589-92. PubMed ID: 21866448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological evaluation of lymph node metastasis on serial sectioning in gastric cancer with radical lymphadenectomy.
    Isozaki H; Okajima K; Fujii K
    Hepatogastroenterology; 1997; 44(16):1133-6. PubMed ID: 9261612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for metastasis to para-aortic lymph nodes in gastric cancer: a single institution study in China.
    Wang L; Liang H; Wang X; Li F; Ding X; Deng J
    J Surg Res; 2013 Jan; 179(1):54-9. PubMed ID: 23040213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of skip lymph node metastasis in gastric cancer patients.
    Kim DH; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Eur J Surg Oncol; 2015 Mar; 41(3):339-45. PubMed ID: 25454830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
    Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
    Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer.
    Espín F; Bianchi A; Llorca S; Feliu J; Palomera E; García O; Remon J; Suñol X
    Eur J Surg Oncol; 2012 Jun; 38(6):497-502. PubMed ID: 22445061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy.
    Lu H; Zhao B; Huang R; Sun Y; Zhu Z; Xu H; Huang B
    BMC Gastroenterol; 2021 Jan; 21(1):15. PubMed ID: 33407177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages.
    Li X; Liu Y; Cao B; Liu B; Bai T; Li X; Mei L; Che X
    Hepatogastroenterology; 2015; 62(138):507-11. PubMed ID: 25916091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma].
    Yu JX; Wu YL; Yang LT
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):922-5. PubMed ID: 16029534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.